IR

Ingersoll Rand Inc.

78
Fundamentals82/ 100
Valuation82/ 100
Upside potential77/ 100
Risk potential11/ 100

IR has the edge over RKLB overall, supported by lower modeled downside and stronger valuation.

RKLB

Rocket Lab USA, Inc.

56
Fundamentals66/ 100
Valuation50/ 100
Upside potential66/ 100
Risk potential46/ 100

RKLB's outlook is improving, though it still trails on the overall score.

IR Fundamentals

MetricStatus
Stable
Strong
Strong
Healthy

IR's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.

RKLB Fundamentals

MetricStatus
Strong
Under pressure
Weak
Unavailable

RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

IR PE Valuation

CHEAPFAIREXPENSIVE22x43x65x86x
CHEAPFAIREXPENSIVE22x43x65x86x
LevelPEPriceVs current
Forward22x$85.31—
Current24x$85.31—
Cheap32x$115+35%
Fair42x$148+73%
Expensive59x$210+146%

Historical ranges are pointers, not guarantees.

IR's PE is in its cheap range at 24x. If earnings grow as analysts expect, today's price would be 22x next year's earnings.

RKLB PE Valuation

RKLB has no meaningful PE right now: it lost money over the past year.

IR Forward outlook

MetricOutlook
Improving
Growth
Growth
Improving
Limited
High

Analysts expect earnings and revenue growth for IR, with profitability improving.

RKLB Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
Low

Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

IR Risk to reward

ScenarioChangePrice
Upside+37%$116.59
Downside-11%$76.19

Calculated from the latest close: $85.31 on Nov 12.

IR has a better modeled risk to reward balance than RKLB, with more potential upside relative to its potential downside.

RKLB Risk to reward

ScenarioChangePrice
Upside+88%$120.71
Downside-46%$34.64

Calculated from the latest close: $64.07 on Nov 12.

RKLB trails IR on modeled risk to reward, with less potential upside relative to its potential downside.

IR Earnings Per Share

Q4 2023: $1.90Q1 2024: $2.01Q2 2024: $2.02Q3 2024: $2.05Q4 2024: $2.06Q1 2025: $2.02Q2 2025: $1.28Q3 2025: $1.35Q4 2025: $1.45Q1 2026: $1.48Q2 2026: $2.43Q3 2026: $3.55Forward: $3.82
Q4 2023: $1.90Q1 2024: $2.01Q2 2024: $2.02Q3 2024: $2.05Q4 2024: $2.06Q1 2025: $2.02Q2 2025: $1.28Q3 2025: $1.35Q4 2025: $1.45Q1 2026: $1.48Q2 2026: $2.43Q3 2026: $3.55Forward: $3.82
QuarterTTM EPSYoY
Forward$3.82+7.5%
Q3 2026$3.55+163%
Q2 2026$2.43+90%
Q1 2026$1.48-27%
Q4 2025$1.45-30%
Q3 2025$1.35-34%
Q2 2025$1.28-37%
Q1 2025$2.02+0.5%
Q4 2024$2.06+8.4%

IR has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.

RKLB Earnings Per Share

Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
QuarterTTM EPSYoY
Q3 2026-$0.36+$0.03
Q2 2026-$0.27+$0.19
Q1 2026-$0.32+$0.09
Q4 2025-$0.37+$0.01
Q3 2025-$0.39-$0.02
Q2 2025-$0.46-$0.11
Q1 2025-$0.41-$0.04
Q4 2024-$0.38$0.00

RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.

IR Quarterly Revenue

Q4 2023: $1.8BQ1 2024: $1.7BQ2 2024: $1.8BQ3 2024: $1.9BQ4 2024: $1.9BQ1 2025: $1.7BQ2 2025: $1.9BQ3 2025: $2BQ4 2025: $2.1BQ1 2026: $1.8BQ2 2026: $2BQ3 2026: $2.1B
Q4 2023: $1.8BQ1 2024: $1.7BQ2 2024: $1.8BQ3 2024: $1.9BQ4 2024: $1.9BQ1 2025: $1.7BQ2 2025: $1.9BQ3 2025: $2BQ4 2025: $2.1BQ1 2026: $1.8BQ2 2026: $2BQ3 2026: $2.1B
QuarterRevenueYoY
Q3 2026$2.1B+5.6%
Q2 2026$2B+8.5%
Q1 2026$1.8B+7.6%
Q4 2025$2.1B+10%
Q3 2025$2B+5.1%
Q2 2025$1.9B+4.6%
Q1 2025$1.7B+2.8%
Q4 2024$1.9B+4.2%

IR's revenue has grown year over year for 18 quarters in a row: $2.1B last quarter, up 5.6% from the same quarter a year ago.

RKLB Quarterly Revenue

Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
QuarterRevenueYoY
Q3 2026$267.8M+73%
Q2 2026$234.1M+62%
Q1 2026$200.3M+63%
Q4 2025$179.7M+36%
Q3 2025$155.1M+48%
Q2 2025$144.5M+36%
Q1 2025$122.6M+32%
Q4 2024$132.4M+121%

RKLB has the edge over IR on sales, with stronger typical year-over-year growth.

IR Free Cash Flow

Q4 2023: $552MQ1 2024: $99MQ2 2024: $283MQ3 2024: $374MQ4 2024: $491MQ1 2025: $223MQ2 2025: $210MQ3 2025: $326MQ4 2025: $462MQ1 2026: $163MQ2 2026: $269MQ3 2026: $623M
Q4 2023: $552MQ1 2024: $99MQ2 2024: $283MQ3 2024: $374MQ4 2024: $491MQ1 2025: $223MQ2 2025: $210MQ3 2025: $326MQ4 2025: $462MQ1 2026: $163MQ2 2026: $269MQ3 2026: $623M
QuarterFree cash flowYoY
Q3 2026$623.3M+91%
Q2 2026$268.9M+28%
Q1 2026$163.4M-27%
Q4 2025$461.5M-6%
Q3 2025$325.5M-13%
Q2 2025$210.4M-26%
Q1 2025$222.7M+124%
Q4 2024$490.9M-11%

IR has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.

RKLB Free Cash Flow

Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
QuarterFree cash flowYoY
Q3 2026-$23.9M+$45.5M
Q2 2026-$110.1M-$54.8M
Q1 2026-$77.4M+$5.5M
Q4 2025-$114.2M-$90.2M
Q3 2025-$69.4M-$27.5M
Q2 2025-$55.3M-$26.9M
Q1 2025-$82.9M-$61.1M
Q4 2024-$23.9M+$28.7M

RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.

IR Total Shares

Q4 2023: 409MQ1 2024: 408MQ2 2024: 407MQ3 2024: 407MQ4 2024: 407MQ1 2025: 406MQ2 2025: 401MQ3 2025: 399MQ4 2025: 401MQ1 2026: 394MQ2 2026: 392MQ3 2026: 388M
Q4 2023: 409MQ1 2024: 408MQ2 2024: 407MQ3 2024: 407MQ4 2024: 407MQ1 2025: 406MQ2 2025: 401MQ3 2025: 399MQ4 2025: 401MQ1 2026: 394MQ2 2026: 392MQ3 2026: 388M
PeriodChange %Net change
Quarterly-1%-3.8M shares
1 year-2.7%-10.9M shares
3 years-5%-20.5M shares
5 years-7.3%-30.4M shares
Available history+86%+179M shares

IR has the edge over RKLB on shareholder dilution, with a more favorable share count trend.

RKLB Total Shares

Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
PeriodChange %Net change
Quarterly+3.6%+22.6M shares
1 year+23%+124M shares
3 years+35%+168M shares
5 years+46%+204M shares

RKLB has 652M diluted shares, up 23% from a year ago.

IR Net Leverage

Q4 2025: 2.1xQ1 2026: 2.1xQ2 2026: 1.8xQ3 2026: 1.4x
Q4 2025: 2.1xQ1 2026: 2.1xQ2 2026: 1.8xQ3 2026: 1.4x
QuarterNet LeverageStatus
Q3 20261.4xHealthy
Q2 20261.8xHealthy
Q1 20262.1xModerate
Q4 20252.1xModerate
Q3 20207.7xHigh
Q2 202011.0xHigh
Q1 202010.2xHigh
Q4 20192.7xModerate

IR's net debt is about 1.4 years of its operating earnings (EBITDA), down from 7.7 years a year ago.

RKLB Net Leverage

RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

IR Weekly Momentum

MetricValueStatus
RSI58.2Neutral
Stochastic62.0Neutral

IR's weekly RSI is 58 (neutral) and its Stochastic is 62 (neutral).

RKLB Weekly Momentum

MetricValueStatus
RSI46.8Neutral
Stochastic27.6Neutral

RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).

IR PE vs Industrials Sector

MetricIRSector medianRelative
PE24x24x0.2% below
PE %25856 pts below

IR is trading at 24x earnings, in line with the Industrials sector's median of 24x.

RKLB PE vs Industrials Sector

RKLB has no meaningful PE right now: it lost money over the past year.

IR Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$78.88.2% above
20 week MA$79.57.3% above
50 week MA$81.25% above
100 week MA$81.64.5% above
200 week MA$79.87% above

IR has the edge over RKLB on trend strength, trading above more of its moving averages.

RKLB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$61.44.3% above
20 week MA$68.15.9% below
50 week MA$77.617% below
100 week MA$56.513% above
200 week MA$31.4104% above

RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.

IR Yearly ROI

YearStart priceEnd priceROI
2020$37.0$46.0+25%
2021$46.0$59.7+30%
2022$59.7$52.3-12%
2023$52.3$77.3+48%
2024$77.3$91.6+18%
2025$91.6$81.3-11%
2026 YTD$81.3$85.3+5%

IR has the edge over RKLB on returns for 2026, with the stronger performance.

RKLB Yearly ROI

YearStart priceEnd priceROI
2020$9.82$10.3+4.9%
2021$10.3$12.0+17%
2022$12.0$3.77-69%
2023$3.77$5.53+47%
2024$5.53$27.2+392%
2025$27.2$70.7+160%
2026 YTD$70.7$64.1-9.3%

RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.

Give your agent the market.

Get API key